pQCXIH-myc-hTAZ Citations (2)

Originally described in: TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.
Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, Zhao S, Xiong Y, Guan KL Mol Cell Biol. 2008 Apr;28(7):2426-36. Epub 2008 Jan 28. PubMed Journal

---

Articles Citing pQCXIH-myc-hTAZ

Articles
TAZ negatively regulates the novel tumor suppressor ANKRD52 and promotes PAK1 dephosphorylation in lung adenocarcinomas. Lee TF, Liu YP, Lin YF, Hsu CF, Lin H, Chang WC, Pan CM, Chou TY, Wu CW. Biochim Biophys Acta Mol Cell Res. 2021 Feb;1868(2):118891. doi: 10.1016/j.bbamcr.2020.118891. Epub 2020 Oct 20. PubMed
Targeting eIF4A-dependent translation in genetically complex sarcoma. Kim YM, Mohan P, Sehrawat U, Seffar E, De Queiroz RM, Chadalavada K, Persaud N, Okada T, Kulkarni A, Lin J, Lailler N, Smith S, Jadeja B, Socci ND, Ouyang Z, Wendel HG, Singer S. JCI Insight. 2026 Apr 7;11(10):e192936. doi: 10.1172/jci.insight.192936. eCollection 2026 May 22. PubMed

If you have published an article using this material, please email us at to have your article added to this page.